Reaction

Product Shape Issue reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 924 reports · 6 co-occurring drugs

As of the last recalculation, Product Shape Issue appears in 924 FAERS reports alongside 6 co-occurring drug terms. The strongest observed disproportionality signal is ETONOGESTREL AND ETHINYL ESTRADIOL (PRR 53.6).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Etonogestrel And Ethinyl Estradiol5053.653.8
Ibuprofen Tablets, Coated2714.714.7
Ibuprofen Sodium2714.614.6
Loratadine And Pseudoephedrine Sulfate38.58.5
Vibegron38.58.5
Levonorgestrel657.77.7

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.